Clinical Trial Search

Primary: Change in CBF From Baseline (Before Start of the Hemodialysis Study Session), at 20 Minutes, and at the End of the Hemodialysis Study Session, Measured by [15O]H2OPET-CT…

Primary: Measurement of Renal Blood Flow of the Kidney by the PAH Method — 190 ml/min

Primary: Regional Cerebral Blood Flow Values of the Brain Measured Using Pseudo-continuous Arterial Spin Labeling (pCASL) MRI. — 35.4 ml/100g/min

Primary: Muscle Satellite Cells — 3.2; 3.2; 4.0; 3.8 Number of Pax7+ cells/muscle fiber

Primary: Changes in Internal Carotid Artery Blood Flow by Treatment of Anaesthesia-induced Hypotension — 27 ml/min — p=0.0276

Primary: Tibial Blood Perfusion — 0.54; -1.47; 0.43; 2.08 μM (concentration)

Primary: Percentage Change From Baseline in Forearm Blood Flow in Response to Increasing Intraarterial Doses of C21 — 27.8; 17.2; 37.0; 28.5 percentage of change from baseline

Primary: Systemic, Pulmonary and Cerebral Blood Flow at Baseline and After Enalaprilat — 1.4; 1.8; 1.9; 1.9 l/min/m2 — p=0.09

Primary: Change From Baseline in Flow Mediated Dilation After 24 Hour Ischemic Conditioning With Blood Pressure Cuff — 6.6 percentage of baseline

Primary: Acute Study: Percentage Flow-Mediated Dilation (FMD) — 7.8; 7.7; 7.3; 6.6 percent flow mediated dilation

Primary: One Repetition Maximum — 302.9 pounds

Primary: Systolic Blood Pressure — 93.21; 107.00; 95.8; 93.84 mmHg

Primary: Feasibility of Performing Echo, BNP, and VP on Human Subjects. — 657; 236 Participants

Primary: Coronary Blood Flow Assessment With Regadenoson Stress by Cardiac MRI Between Non-diabetic and Type 1 Diabetic Subjects. — 2.19; 1.81; 1.95 percentage of StressMBF/ Rest…

Primary: Mean Blood Flow Velocity in Middle Cerebral Artery — 63.7; 61.8 cm/s — p=0.554

Primary: Mean Arterial Pressure-Middle Cerebral Artery Blood Velocity Very Low Frequency Phase (Radians) — 1.38; 1.12; 1.40; 1.60 Radians — p=0.05

Primary: Mixed Muscle Fractional Synthesis Rate (FSR) — 0.061; 0.070; 0.066; 0.070 Fractional Synthesis Rate (pecent/hour)

Primary: The Percentage of Change in Optical Cerebral Blood Flow (oCBF) During Bolus Normal Saline Compared to Baseline, as Measured by Diffuse Correlation Spectroscopy (DCS)…

Primary: Internal Jugular Venous (IJV) Cross Sectional Area — 1.2; 1.0; 1.8; 1.4 cm2

Primary: 6-month Change in Ophthalmic Artery (OA) Peak Systolic Velocity (PSV) — -.70; 1.84 cm/sec — p=.4414

Primary: Blood Volume — 4.61 Litre

Primary: Blood Flow - Peak Systolic Velocity (cm/Sec) — 14.1; 29.5; 161.6; 39.0 cm/s

Primary: Change in Systolic Blood Pressure — 43; 21 mm Hg

Primary: dCA Measurement During Acute Changes in Mean Arterial Pressure, TCD — 0.262 per second

Primary: Presence of Retinal Blood Flow Autoregulation — 14 participants — p=<0.0001

Primary: Quadricep Muscle Strength — 86.15; 76.55; 91.03; 80.32 torque newton-meter

Primary: Change From Baseline in Saphenous Vein Bypass Graft Vasodilation — 5.28 vein bypass graft size increase (%)

Primary: Modulation of Levels of Total Haemoglobin — 1.9; 2.4; 1.2 µmol/L — p=>0.05

Primary: Change in Cerebral Blood Flow (CBF) at Baseline Between Obstructive Sleep Apnea Syndrome (OSAS) and Controls — 184; 209 percentage of change from baseline

Primary: Change From Baseline Work Capacity at 13 Weeks — -1.20; -0.18 change in ml/kg/min — p=0.660